Cargando…

Infection control knowledge, beliefs and behaviours amongst cystic fibrosis patients with epidemic Pseudomonas aeruginosa

BACKGROUND: Epidemic P. aeruginosa (ePA) infections are common in cystic fibrosis (CF) and have been associated with accelerated clinical decline. Factors associated with ePA are unclear, and evidence based infection control interventions are lacking. METHODS: We prospectively collect all bacterial...

Descripción completa

Detalles Bibliográficos
Autores principales: Somayaji, R., Waddell, B., Workentine, M. L., Surette, M. G., Brager, N. P., Rabin, H. R., Parkins, M. D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635525/
https://www.ncbi.nlm.nih.gov/pubmed/26542115
http://dx.doi.org/10.1186/s12890-015-0116-x
_version_ 1782399514100891648
author Somayaji, R.
Waddell, B.
Workentine, M. L.
Surette, M. G.
Brager, N. P.
Rabin, H. R.
Parkins, M. D.
author_facet Somayaji, R.
Waddell, B.
Workentine, M. L.
Surette, M. G.
Brager, N. P.
Rabin, H. R.
Parkins, M. D.
author_sort Somayaji, R.
collection PubMed
description BACKGROUND: Epidemic P. aeruginosa (ePA) infections are common in cystic fibrosis (CF) and have been associated with accelerated clinical decline. Factors associated with ePA are unclear, and evidence based infection control interventions are lacking. METHODS: We prospectively collect all bacterial pathogens from adult CF patients. We performed PA strain typing on retrospectively collected enrolment samples and recent isolates to identify patients infected with ePA. All patients attending our clinic were approached to complete a survey on infection control knowledge, beliefs and exposures. We analyzed responses of those with ePA relative to the entire cohort without ePA as well as those infected with unique strains of P. aeruginosa to assess for risk factors for ePA and differences in infection control knowledge, beliefs or behaviours. RESULTS: Of 144 participants, 30 patients had ePA (two Liverpool epidemic strain, 28 Prairie epidemic strain), 83 % of which had established infection prior to transition to the adult clinic. Risk of concomitant infecting pathogens was no different between groups although, Staphylococcus aureus and non-tuberculous mycobacteria were less common in those with ePA. Patients with ePA were more likely to have attended CF-camp and have a history of CF fundraising. Patients with ePA did not differ with respect to beliefs regarding pathogens or transmission risk, except they believed indirect contact posed little risk. Furthermore, patients with ePA were more likely to continue to associate with others with CF despite extensive counselling. Use of peer-peer online networking was minimal in both groups. CONCLUSION: Infections with ePA are closely linked to past exposures, now routinely discouraged. As socialization is the greatest risk factor for ePA, infection control strategies for ePA must focus on discouraging face-to-face interactions amongst CF patients. As peer support remains a desire amongst patients, investment in technologies and strategies that enable indirect communication and support are required.
format Online
Article
Text
id pubmed-4635525
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46355252015-11-07 Infection control knowledge, beliefs and behaviours amongst cystic fibrosis patients with epidemic Pseudomonas aeruginosa Somayaji, R. Waddell, B. Workentine, M. L. Surette, M. G. Brager, N. P. Rabin, H. R. Parkins, M. D. BMC Pulm Med Research Article BACKGROUND: Epidemic P. aeruginosa (ePA) infections are common in cystic fibrosis (CF) and have been associated with accelerated clinical decline. Factors associated with ePA are unclear, and evidence based infection control interventions are lacking. METHODS: We prospectively collect all bacterial pathogens from adult CF patients. We performed PA strain typing on retrospectively collected enrolment samples and recent isolates to identify patients infected with ePA. All patients attending our clinic were approached to complete a survey on infection control knowledge, beliefs and exposures. We analyzed responses of those with ePA relative to the entire cohort without ePA as well as those infected with unique strains of P. aeruginosa to assess for risk factors for ePA and differences in infection control knowledge, beliefs or behaviours. RESULTS: Of 144 participants, 30 patients had ePA (two Liverpool epidemic strain, 28 Prairie epidemic strain), 83 % of which had established infection prior to transition to the adult clinic. Risk of concomitant infecting pathogens was no different between groups although, Staphylococcus aureus and non-tuberculous mycobacteria were less common in those with ePA. Patients with ePA were more likely to have attended CF-camp and have a history of CF fundraising. Patients with ePA did not differ with respect to beliefs regarding pathogens or transmission risk, except they believed indirect contact posed little risk. Furthermore, patients with ePA were more likely to continue to associate with others with CF despite extensive counselling. Use of peer-peer online networking was minimal in both groups. CONCLUSION: Infections with ePA are closely linked to past exposures, now routinely discouraged. As socialization is the greatest risk factor for ePA, infection control strategies for ePA must focus on discouraging face-to-face interactions amongst CF patients. As peer support remains a desire amongst patients, investment in technologies and strategies that enable indirect communication and support are required. BioMed Central 2015-11-05 /pmc/articles/PMC4635525/ /pubmed/26542115 http://dx.doi.org/10.1186/s12890-015-0116-x Text en © Somayaji et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Somayaji, R.
Waddell, B.
Workentine, M. L.
Surette, M. G.
Brager, N. P.
Rabin, H. R.
Parkins, M. D.
Infection control knowledge, beliefs and behaviours amongst cystic fibrosis patients with epidemic Pseudomonas aeruginosa
title Infection control knowledge, beliefs and behaviours amongst cystic fibrosis patients with epidemic Pseudomonas aeruginosa
title_full Infection control knowledge, beliefs and behaviours amongst cystic fibrosis patients with epidemic Pseudomonas aeruginosa
title_fullStr Infection control knowledge, beliefs and behaviours amongst cystic fibrosis patients with epidemic Pseudomonas aeruginosa
title_full_unstemmed Infection control knowledge, beliefs and behaviours amongst cystic fibrosis patients with epidemic Pseudomonas aeruginosa
title_short Infection control knowledge, beliefs and behaviours amongst cystic fibrosis patients with epidemic Pseudomonas aeruginosa
title_sort infection control knowledge, beliefs and behaviours amongst cystic fibrosis patients with epidemic pseudomonas aeruginosa
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635525/
https://www.ncbi.nlm.nih.gov/pubmed/26542115
http://dx.doi.org/10.1186/s12890-015-0116-x
work_keys_str_mv AT somayajir infectioncontrolknowledgebeliefsandbehavioursamongstcysticfibrosispatientswithepidemicpseudomonasaeruginosa
AT waddellb infectioncontrolknowledgebeliefsandbehavioursamongstcysticfibrosispatientswithepidemicpseudomonasaeruginosa
AT workentineml infectioncontrolknowledgebeliefsandbehavioursamongstcysticfibrosispatientswithepidemicpseudomonasaeruginosa
AT surettemg infectioncontrolknowledgebeliefsandbehavioursamongstcysticfibrosispatientswithepidemicpseudomonasaeruginosa
AT bragernp infectioncontrolknowledgebeliefsandbehavioursamongstcysticfibrosispatientswithepidemicpseudomonasaeruginosa
AT rabinhr infectioncontrolknowledgebeliefsandbehavioursamongstcysticfibrosispatientswithepidemicpseudomonasaeruginosa
AT parkinsmd infectioncontrolknowledgebeliefsandbehavioursamongstcysticfibrosispatientswithepidemicpseudomonasaeruginosa